scholarly journals Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development

2020 ◽  
Vol 241 ◽  
pp. 34-41 ◽  
Author(s):  
Jan Köster ◽  
Elsa Arbajian ◽  
Björn Viklund ◽  
Anders Isaksson ◽  
Jakob Hofvander ◽  
...  
2010 ◽  
Vol 130 (3) ◽  
pp. 904-907 ◽  
Author(s):  
Damien Giacchero ◽  
Georges Maire ◽  
Paulo A.S. Nuin ◽  
Frédéric Berthier ◽  
Nathalie Ebran ◽  
...  

2009 ◽  
Vol 61 (1) ◽  
pp. 130-132 ◽  
Author(s):  
Takenori Kabumoto ◽  
Hiroshi Fujiwara ◽  
Naoyuki Kariya ◽  
Tomotaka Tsujimoto ◽  
Kaoru Ito ◽  
...  

Sarcoma ◽  
2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Piotr Rutkowski ◽  
Agnieszka Wozniak ◽  
Tomasz Switaj

The molecular pathogenesis of dermatofibrosarcoma protuberans (DFSP) involves distinctive rearrangement of chromosomes 17 and 22 leading to formation of theCOL1A1-PDGFBfusion gene. The knowledge of molecular events underlying development of DFSP resulted in the implementation of targeted therapy with imatinib—a tyrosine kinase inhibitor (TKI), to the clinical practice. The striking efficacy of imatinib in advanced cases of DFSP has been demonstrated in a few clinical trials. Thus, imatinib is currently considered the gold standard in the treatment of inoperable and/or metastatic and/or recurrent cases of DFSP. Therapy with imatinib may potentially facilitate resection or decrease possible disfigurement related to radical surgical procedure. Following partial response on imatinib significant percentage of patients may be rendered free of the disease by surgery of the residual tumor.


Folia Medica ◽  
2020 ◽  
Vol 62 (1) ◽  
pp. 17-22
Author(s):  
Artur Kowalik ◽  
Andrzej Wincewicz ◽  
Sebastian Zięba ◽  
Janusz Kopczynski ◽  
Mariusz Koda ◽  
...  

We examined a status of fibrosarcoma arising in dermatofibrosarcoma protuberans of 64-year-old male patient. A dermal, solid, grayish-yellow, desmin-negative trichrome-bluish tumor measured 1.5 cm in diameter pT1a (edition 8 pTNM). It was composed of spindle cells. It was consistent with dermatofibrosarcoma protuberans (ICD-O3: 8832/3) in areas of low mitotic activity, low atypia and sustained CD34 positivity. CD34-negative texture with high mitotic index and atypia was consistent with the high grade sarcoma apparently of fibrous origin, given category of poorly differentiated fibrosarcoma. The high grade component was graded (G3) and scored according to French Federation of Cancer Centers Sarcoma Group (FNCLCC): total score of 6 points: tumor differentiation: 3 points + Mitotic count: 3 points (up to 26 mitoses/ 10HPF in high-grade fields), + no necrosis: 0 points. In low grade sarcomatous component ADAMTS20 (NM_025003: c.1661C>T, p.P554L) NF1 (NM_001042492: c. 2173G>T, p.E725X) and PKHD1 (NM_138694: c. 11074C>T, p.R3692X) were revealed with following allelic frequencies: 25%, 27% and 17%. In high grade component allelic frequencies of the same mentioned mutations were 30%, 30% and 14% respectively. In the light of our findings, none of detected mutations can be regarded as a mutation that would definitely induce phenotype of high malignancy, because ADAMTS20, NF1 and PKHD1 mutations were detected both in high grade sarcoma and in low grade areas of dermatofibrosarcoma protuberans. It also points that these mutations appeared on early stages of tumor development.


2020 ◽  
Vol 45 (8) ◽  
pp. 1067-1068
Author(s):  
S. Otsuka‐Maeda ◽  
I. Kajihara ◽  
H. Kanemaru ◽  
S. Sawamura ◽  
K. Makino ◽  
...  

2010 ◽  
Vol 20 (3) ◽  
pp. 390-391
Author(s):  
Faith C. Muchemwa ◽  
Masatoshi Jinnin ◽  
Shoji Wakasugi ◽  
Maki Sakamoto ◽  
Yuji Inoue ◽  
...  

Skin Cancer ◽  
2021 ◽  
Vol 36 (1) ◽  
pp. 55-59
Author(s):  
Madoka INOUE ◽  
Yuki MIZUTANI ◽  
Kanako MATSUYAMA ◽  
En SHU ◽  
Masatoshi JINNIN ◽  
...  

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 10570-10570
Author(s):  
C. Kesserwan ◽  
R. Sokolic ◽  
E. Cowen ◽  
E. Garabedian ◽  
S. Pittaluga ◽  
...  

10570 Background: DFSP is a rare malignant skin tumor associated with a characteristic chromosomal translocation (t(17;22)(q22;q13)), resulting in the COL1A1-PDGFB fusion gene. We originally diagnosed DFSP in two patients affected with a rare form of severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID). The association of these two rare conditions has been described in two other cases, which prompted us to screen for DFSP systematically in patients with ADA-SCID. Methods: Eight ADA-SCID patients were evaluated with complete dermatological exam and skin biopsy. Molecular analysis (FISH and/or RT-PCR) and karyotype were performed when possible. Results: Six patients (age 2, 2, 5, 9, 12 and 22 years) were found to have DFSP. Five patients had between 4 and 12 multicentric lesions over the trunk and extremities. One patient had a single lesion. Most lesions appeared as 2–15 mm tan atrophic plaques. Nodular lesions were present in 3 patients. All lesions showed a spindle cell proliferation of the dermis, extending into the subcutaneous fat. A storiform pattern was only noticed in one adult patient. In all cases, CD34 expression was diffusely positive and FXIIIa was negative. Karyotype showed t(17;22)(q22;q13) in the 2 patients in whom it was performed. FISH was positive for COL1A1-PDGFB in 2 of 4 patients studied. RT-PCR showed the COL1A1-PDGFB fusion transcript in one case in which FISH was inconclusive.FISH and RT-PCR analyses are being conducted in 2 and 5 remaining cases, respectively. Conclusions: We describe a previously unrecognized association between multicentric DFSP and ADA-SCID. Multicentricity of DFSP to this extent has not previously been reported . We hypothesize that t(17;22)(q22;q13) may arise due to the known DNA repair defect in ADA-SCID and that the known dermal overexpression of PDGFB in this condition may favor the development of fibrotic tumors, as opposed to other skin cancers. Our observations can provide further insight into the pathogenesis of DFSP and should facilitate early diagnosis of DFSP in ADA-SCID. No significant financial relationships to disclose.


2008 ◽  
Vol 29 (11) ◽  
pp. 2062-2072 ◽  
Author(s):  
Marie-Noëlle Laguë ◽  
Marilène Paquet ◽  
Heng-Yu Fan ◽  
M. Johanna Kaartinen ◽  
Simon Chu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document